Sep 17, 2025 01:30AM

Mar 14, 2025 02:30AM

Mar 7, 2025 01:30AM

Dec 18, 2024 01:30AM

Sep 23, 2024 01:30AM

Sep 18, 2024 01:30AM

Sep 12, 2024 01:30AM Sensorion Announces Its Participation in the 59th Annual Inner Ear Biology Workshop

Jul 23, 2024 01:30AM

Jul 15, 2024 01:30AM

Jun 20, 2024 01:30AM

Mar 14, 2024 02:30AM

Mar 11, 2024 02:30AM

Feb 1, 2024 01:30AM

Jan 19, 2024 01:30AM Sensorion Announces Approval to Initiate Lead Gene Therapy Candidate SENS-501 (OTOF-GT) into a Phase 1/2 Clinical Trial in some European Countries

Dec 18, 2023 01:30AM

Sep 20, 2023 01:30AM

Jul 19, 2023 01:30AM

Jul 10, 2023 01:30AM

Jul 5, 2023 01:30AM

Jun 19, 2023 01:30AM

Jun 7, 2023 01:30AM Sensorion to Host Key Opinion Leader Webinar on July 5, 2023; Confirms Upcoming Key Milestones

Mar 16, 2023 02:30AM

Jan 3, 2023 01:30AM

Nov 30, 2022 01:30AM

Nov 7, 2022 01:30AM

Oct 24, 2022 01:30AM

Oct 6, 2022 01:30AM

Sep 22, 2022 01:30AM Sensorion Reports 2022 First Half Results

Sep 14, 2022 01:30AM

Jul 1, 2022 01:30AM

Jun 7, 2022 01:30AM

Mar 17, 2022 02:30AM

Feb 3, 2022 01:30AM

Jan 17, 2022 01:30AM

Oct 27, 2021 01:30AM Sensorion Surpasses Enrollment Target for SENS-401 in SSNHL, Results Available in January 2022

Sep 24, 2021 01:30AM

Sep 8, 2021 02:30AM

Jun 10, 2021 02:30AM

Apr 2, 2020 01:30AM

Mar 13, 2020 02:30AM

Feb 17, 2020 01:30AM

Jan 30, 2020 01:30AM Sensorion Presents New SENS-401 Preclinical Data at ARO Midwinter Meeting 2020

Dec 23, 2019 11:40AM

Dec 23, 2019 01:30AM

Nov 7, 2019 01:30AM

Oct 23, 2019 01:30AM

Sep 11, 2019 01:30AM

Jul 12, 2019 01:30AM

Jun 28, 2019 01:30AM Sensorion Receives European Medicines Agency Agreement on the Pediatric Investigation Plan (PIP) for Arazasetron (SENS-401) in Two Indications

Feb 13, 2019 01:30AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All